| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $179.5M | +8.2% |
| Cost of Revenue | $54.1M | +4.6% |
| Gross Profit | $125.3M | +9.8% |
| R&D Expense | $53.6M | +5.6% |
| SG&A Expense | $69.9M | +12.4% |
| Pre-tax Income | $6.6M | +35.1% |
| Income Tax | $2.5M | +43.0% |
| Net Income | $4.1M | +30.7% |
| EPS (Basic) | $0.11 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $90.6M | -8.5% |
| Short-term Investments | $24.3M | -33.5% |
| Accounts Receivable | $73.6M | +64.0% |
| Current Assets | $206.0M | +4.1% |
| Total Assets | $315.3M | +8.7% |
| Current Liabilities | $60.5M | +19.1% |
| Total Liabilities | $69.3M | +13.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $9.7M | -33.5% |
| Capital Expenditures | $17.2M | +52.7% |
| Investing Cash Flow | -$5.9M | +79.5% |
| Financing Cash Flow | -$11.2M | -90.7% |
| Free Cash Flow | -$7.5M | -321.5% |
| +37.5% |
| EPS (Diluted) | $0.10 | +25.0% |
| Stockholders' Equity |
| $246.0M |
| +7.5% |